Movement Alert｜EVEREST MED Declines 5.04% in Regular Trading, Trading at HK$27.54

Market Focus09-24

On September 24, EVEREST MED fell 5.04% in regular trading, trading at HK$27.54 per share, with turnover of HK$65.82 million.

Within the Biotechnology sector where EVEREST MED belongs, the sector broadly came under selling pressure. Among individual stocks, AKESO down 3.54%, INNOVENT BIO down 3.48%, BEONE MEDICINES down 1.47%, REMEGEN down 5.84%, 3SBIO down 3.88%.

EVEREST MED is a biopharmaceutical company primarily engaged in the R&D, clinical development, manufacturing, and commercialization of innovative drugs and vaccines. Its product pipeline spans nephrology, anti-infectives, and autoimmune diseases, with key products including TARPEYO for kidney disease and XERAVA for multi-drug resistant infections.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122725078?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-24 10:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122725078","market":"hk","top_or_hot":-1,"title":"Movement Alert｜EVEREST MED Declines 5.04% in Regular Trading, Trading at HK$27.54","media":"Market Focus","content":"<p><p>On September 24, EVEREST MED fell 5.04% in regular trading, trading at HK$27.54 per share, with turnover of HK$65.82 million.</p><p>Within the Biotechnology sector where EVEREST MED belongs, the sector broadly came under selling pressure. Among individual stocks, AKESO down 3.54%, INNOVENT BIO down 3.48%, BEONE MEDICINES down 1.47%, REMEGEN down 5.84%, 3SBIO down 3.88%.</p><p>EVEREST MED is a biopharmaceutical company primarily engaged in the R&D, clinical development, manufacturing, and commercialization of innovative drugs and vaccines. Its product pipeline spans nephrology, anti-infectives, and autoimmune diseases, with key products including TARPEYO for kidney disease and XERAVA for multi-drug resistant infections.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜EVEREST MED Declines 5.04% in Regular Trading, Trading at HK$27.54</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜EVEREST MED Declines 5.04% in Regular Trading, Trading at HK$27.54\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-24 10:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 24, EVEREST MED fell 5.04% in regular trading, trading at HK$27.54 per share, with turnover of HK$65.82 million.</p><p>Within the Biotechnology sector where EVEREST MED belongs, the sector broadly came under selling pressure. Among individual stocks, AKESO down 3.54%, INNOVENT BIO down 3.48%, BEONE MEDICINES down 1.47%, REMEGEN down 5.84%, 3SBIO down 3.88%.</p><p>EVEREST MED is a biopharmaceutical company primarily engaged in the R&D, clinical development, manufacturing, and commercialization of innovative drugs and vaccines. Its product pipeline spans nephrology, anti-infectives, and autoimmune diseases, with key products including TARPEYO for kidney disease and XERAVA for multi-drug resistant infections.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1122725078","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122725078","pubTimestamp":1790216198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 24, EVEREST MED fell 5.04% in regular trading, trading at HK$27.54 per share, with turnover of HK$65.82 million.Within the Biotechnology sector where EVEREST MED belongs, the sector...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"走势提醒|珠峰地中海常规交易跌5.04%，报27.54港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"On September 24, EVEREST MED fell 5.04% in regular trading, trading at HK$27.54 per share, with turnover of HK$65.82 million.Within the Biotechnology sector where EVEREST MED belongs, the sector broadly came under selling pressure. Among individual stocks, AKESO down 3.54%, INNOVENT BIO down 3.48%, BEONE MEDICINES down 1.47%, REMEGEN down 5.84%, 3SBIO down 3.88%.EVEREST MED is a biopharmaceutical company primarily engaged in the R&D, clinical development, manufacturing, and commercialization of innovative drugs and vaccines. Its product pipeline spans nephrology, anti-infectives, and autoimmune diseases, with key products including TARPEYO for kidney disease and XERAVA for multi-drug resistant infections.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122725078","isCrawlerRequest":true}